Lunch break symposium supported by Opella
Chair(s)
To be confirmed
Introduction:
Erectile dysfunction (ED) affects millions worldwide and is increasingly recognised as a significant marker of cardiovascular and metabolic disease, not only as a sexual health concern. This symposium brings together experts to discuss how pharmacists can strengthen early detection, provide safe and evidence-based treatment guidance, and contribute to integrated care pathways that support overall men’s health.
Programme:
| 13:00 – 13:04 | Welcome |
| Opella representative |
| 13:04 – 13:07 | Introduction |
| FIP representative |
| 13:07 – 13:17 | Understanding erectile dysfunction |
| Speaker to be confirmed |
| 13:17 – 13:32 | Erectile dysfunction in pharmacy practice |
| Speaker to be confirmed |
| 13:32 – 13:42 | FIP Erectile Dysfunction Handbook |
| Speaker to be confirmed |
| 13:42 – 13:57 | Panel discussion |
| 4 speakers (GP/nurse practitioner, pharmacist, FIP and Opella) |
| 13:57 – 14:00 | Closure |
| FIP representative |
Learning objectives:
1. Recognise erectile dysfunction as an early indicator of cardiometabolic risk, supporting pharmacists’ role in early identification, patient education, and appropriate referral within routine pharmacy practice.
2. Understand evidence-based principles for erectile dysfunction management, including safety considerations and lifestyle interventions, to support accurate counselling and responsible engagement with patients.
3. Explore how person-centred consultation principles support structured, empathetic discussions around erectile dysfunction and broader men’s health.
Take home messages:
Erectile dysfunction is common and clinically significant, often signalling underlying cardiometabolic risk. Pharmacists are well placed to support early identification, patient education, empathetic discussions, lifestyle counselling, and appropriate referral, contributing to improved men’s health outcomes through accessible, people-centred pharmacy practice.
